PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 28, 2009International Psychogeriatrics167 citationsOpen Access

Trajectories of cognitive decline in Alzheimer's disease

View Full Paper
PWPatricia A. WilkoszHSHoward SeltmanBDBernie Devlin

Key Points

Key points are not available for this paper at this time.

Abstract

BACKGROUND: Late-onset Alzheimer disease (LOAD) is a clinically heterogeneous complex disease defined by progressively disabling cognitive impairment. Psychotic symptoms which affect approximately one-half of LOAD subjects have been associated with more rapid cognitive decline. However, the variety of cognitive trajectories in LOAD, and their correlates, have not been well defined. We therefore used latent class modeling to characterize trajectories of cognitive and behavioral decline in a cohort of AD subjects. METHODS: 201 Caucasian subjects with possible or probable Alzheimer's disease (AD) were evaluated for cognitive and psychotic symptoms at regular intervals for up to 13.5 years. Cognitive symptoms were evaluated serially with the Mini-mental State Examination (MMSE), and psychotic symptoms were rated using the CERAD behavioral rating scale (CBRS). Analyses undertaken were latent class mixture models of quadratic trajectories including a random intercept with initial MMSE score, age, gender, education, and APOE 4 count modeled as concomitant variables. In a secondary analysis, psychosis status was also included. RESULTS: AD subjects showed six trajectories with significantly different courses and rates of cognitive decline. The concomitant variables included in the best latent class trajectory model were initial MMSE and age. Greater burden of psychotic symptoms increased the probability of following a trajectory of more rapid cognitive decline in all age and initial MMSE groups. APOE 4 was not associated with any trajectory. CONCLUSION: Trajectory modeling of longitudinal cognitive and behavioral data may provide enhanced resolution of phenotypic variation in AD.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wilkosz et al. (2009) studied this question.

synapsesocial.com/papers/6a62828b44847eed21c958behttps://doi.org/10.1017/s1041610209991001
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Implications of latent trajectory models for the study of developmental psychopathology2003 · 150 citations
  2. 2Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families1993 · 9,541 citations
  3. 3Case-control studies in the genomic era: a clinician's guide2006 · 53 citations
  4. 4Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)1996 · 3,980 citations
  5. 5Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database2006 · 1,908 citations